FDA Clearance Tracker · P100026
NEUROPACE RNS SYSTEM
Last checked: Nov 20, 2026Latest source record: Nov 14, 2013 (this decision)Source: openFDAMethods & limitations
Decided
Nov 14, 2013
Approved
Time to decision
1,231 days
Received Jul 2, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P100026
- Device name
- NEUROPACE RNS SYSTEM
- Applicant
- NeuroPace, Inc.
- Applicant location
- Mountain View, CA
- Received
- Jul 2, 2010
- Decided
- Nov 14, 2013
- Decision
- Approved
- Supplements
- 98 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE RNS SYSTEM. THIS DEVICE IS INDICATED AS FOLLOWS: " ... AS AN ADJUNCTIVE THERAPY IN REDUCING THE FREQUENCY OF SEIZURES IN INDIVIDUALS 18 YEARS OF AGE OR OLDER WITH PARTIAL ONSET SEIZURES WHO HAVE UNDERGONE DIAGNOSTIC TESTING THAT LOCALIZEDNO MORE THAN 2 EPILEPTOGENIC FOCI, ARE REFRACTORY TO TWO OR MORE ANTIEPILEPTIC MEDICATIONS, AND CURRENTLY HAVE FREQUENT AND DISABLING SEIZURES (MOTOR PARTIAL SEIZURES, COMPLEX PARTIAL SEIZURESAND/ OR SECONDARILY GENERALIZED SEIZURES). THE RNS SYSTEM HAS DEMONSTRATED SAFETY AND EFFECTIVENESS IN PATIENTS WHO AVERAGE 3 OR MORE DISABLING SEIZURES PER MONTH OVER THE THREE MOST RECENT MONTHS (WITH NO MONTH WITH FEWER THAN TWO SEIZURES), AND HAS NOT BEEN EVALUATED IN PATIENTS WITH LESS FREQUENT SEIZURES."
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code PFN (Implanted brain stimulator for epilepsy).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for NeuroPace, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.